Osa-phasi05g0102


Function Link


Basic Info

Source:

XM_026025405.1

Strand on PHAS Transcript:

-

Start on PHAS Transcript:

329

Sequence:

AGGUUGUUGAUGGUAAUCCUG

Length:

21

PHAS Gene Name:

LOC112938990

Chr:

Chr5

PHAS Transcript Annotation:

uncharacterized LOC112938990, transcript variant X2

PHAS Transcript Sequence:

CGCCACCUUUGUCAGCCUUCACCAGUAGCAAUCUCAUGAUCAAACUCUAGACUACACAACUCGGUCACUCAGAGACUUUCAUCGAACGCCUCAUGGGCACGAAGAACAUAUGACUCAAUUUUUGCGAUGCGAAGAACUUAUCGCCUUUUGUCAGUUUUUCUCUCCUCUUAUUGAAUAGCAGUUACAACGUGAGACAUGGACAGUGGCGAGUUGUAUCCUAAAUGCCCCAGGAGAGGCACACAACGAAGAAAGAGGAAACAAAACAGCAAACAGCUAGAAUGACAUCUAAAUUAAGCUAAGUUGAAGAACAGGAUUACCAUCAACAACCUAGGUUGUUGAUGGUAAUCCUGUAGACAAUCGAAGCCUUGUUGCUAAACCUGCAAUCCUGAUGUCUCUUAUGCCCAAUUCCAAUUUGUUAAGUACCCCACACAUGCACCCACUGUCUGACUUUCUGAUCAACUAAAUUUUCUGAUCUUGAGAGUCGAAUGAUUUGCACCUUCUGUUUCAUGUCCAAUUCUAAACCUUCCUUCUUGCCAUUUCAAAGCUGCCCUGCUCUCCAUUCUCUCAAAUGUGAUGCAAGAACUGCAUGUGUGUGGAAGGAUGAAUGAUUGCCGUUCAAAAAUUUUUGAAGAGAUAUAAUAUCUUUGCAAUUGCUAGCCAAGAUCAAAGAGGAGGGUAGAGCAUGGGUUAAAGCCGGAGCGACAAGGCUCUAGGAGUUUGGAAUUUUGGGAGAUACCACCUAAUGAUCUGUUUCUAUGGGUCGGUCGUCUUUUUAGACUGACCCUGUAUAUACUUUUGUAUAAUUUUUUCACUCUCUAUUAAUAUACGGGGCAAAGCUUUGCCCCUCCUUAAAAAAAAGCAUUUGUAAUUCUUUCUUCUCAUAGAACGACACUCAAAGCUUUCGCCUGUUCCACCGAACAAGUUUCUCAUGUAACAAGUUUUUCAAUGAACACAAACUUGCUCCUUUUAUGGUAAAAAAGACAUGCUCGGUGUAAAUGUGAAGACGUAGGAUUAUAUAUGUAGAUAUACAUACUGUACUUCAGUAACACAUAUAUAUCGAAUGACCAUUCUAUGAUUUCUUCUUCCUGAGUACAAAAAUGACUCUCAGAUUCGUUUUGAGCUUAAACAUUCCAAUCCUUGCCAGCUGAAACUGCUUUAAUUAGAUGUGGGACACUCCGACACUAGACAGUUCUUUCUCAGUUUACCGAUGAUCAUCUGCACUCUCCUAGUCCACUAGAUUGAUUUCAGCAACCGAACAUGUCCGUGGAAGUGUGCAGCAACGAGAAAGUUUGCUACUGCAGGGAAGAAGUGAACAUCCCAGUGCAACUGGACAAUCACUAAUUUGGUCAUUCUUUGCAGGAGAAUUUUGUUUUCGAGAAGAGAUCAACUUCUUCCUUUCACAGAGCAUUGACUUGAGCCAAUGUUCAGUCAUCCUGAUGACUACCAUUCCUUUCUUAUUCAUCUACAAGUUGGAAGUUUAGAAGAGAACACAGUCAUCAAAAUAAUGCAUCUGACAUCUCAACCCUUCCUGCAUAUAUGCAUCUCUCUUUAACUCUAGAUGCUGUUAUAUAGAGAGAAGCUAGGUAGGCUAGGGUAGUUCUCAACAGGAGUGAGGCCAUCAAUCAGUGUGGGAUGAGAAAAUUGCAAUUAUAGGACUCCAAACAAUGCGCUUCGCAGUUAUAGGACUCUAAUCGUCGACUUCGCUAAAACGACCCUUGAAACAUUAGCACUUUAUUUUACAUGACAUUUGGUCCUUUUAAUUACUUUUCUCAACUAAAAUACAUGUAUUUUGCCCUAAAGUGACCGUAUUGCCAUUCUGCCUUCUGUAUACUUGAUUGAUCGUAUCUUUUCAUCUCGUCCGAGUCCGCCGUCGUCGUUUCUCCUUCCCUCCCCACACCCUCGGCUCCCAUGGAUGGAGUGCCGCCGCCCGAAGAUGGAGAUGGACGCCCGAUCGCCAUGGAAGGCCAAGCAGCUGAAGACCUAGCGGCUUCUGCCCUAGCCGCUCGGGGUCUAGUCACGCCGCCUGGUGGCCUGGGCUUUGAUGCCUUGGCAGUGGCAGCCGAUGGCCAUGUACAGCAGAAUGCCAACGCUAGUGCUCUAGUCACUGCUAGAACAUUGCUGCCCAAUGCUCCUCUUCCGGCAGCAAUGGAGAUCAACCUUCCUGUUCUUCAAGUGCAAAGGUAUUGGCUGCACUAGUUUUCUGUUUUUUUUUACCACGAUAGUAGUACACAGUAGUAAAACUUGAUUUCACUUGUUUAGGUCCCAAGUAGAUCAUGUGGAAAAUAUGGAAAGAGUUGAUUGGGAUAACAUACACAUAGUCGAGACACAUGAUGACGAAGGUCGUAUUGCACUUAUGAGUGAAUCGCAGAUUUGUGAGCUUUUAGGCGUGAUAGAGGAGGACACAACAAAUAUACCUGCACAGGGCUUUGGUUGCCGAAUGUAUGAACAGGGGCAUGAUAGUGAGCUUGGGCAAAAUAAUGAUGGUGCUGCCAUUCCUACUAGUGAUGAGGUACCGGGUGAGAUGGUCAUUUCAUAUGAUAAGAACAACCCAUCCAUGGCUUUAGGAACAAUGUACCCAACAAUGGAGGAGUUCAAUUUGGCAGUGCGGCAAUUUGCCAUUAAGGAGGAAUUUGAUUUAGGAGUAGAGAAGUCGUGUAAGACGAGAUAUAGGGCUUAUUGCAAGUCCGGUGAUGAAGAUUGCCCUUGCACUUGGAGGAUAAAUGGCACCAAACAAAAAGGCCAAAGCACUGUGGAGGUAAAUAAAUUUAUGUUUUCUUUCAUUAAUUCUACUUUUUAUGUAAAUUAACAUGAAUCUCUUUGAUUUUUUUGUUUUGCAGAUAACUGUCAUAGUCGAUAAGCAUACAUGUGUGUCUAGCAUGAGGCAGAUAACUACAACUCCAACUCUGAAGUGGGUAGCUAGCAAGGCUGUGAGUAUCCUUAGAGAUGAUCCAAAUAUUGGCGCUAAGAGAUUGCAAAACAGGUUGCAGACAGAUCACAAGUGUGAAAUUUCAUAUGACACUGUAUGGCAGGGUAAAGAAAGAGCUCUUGAAGAGGUUUAUGGCAAAUGGGAAGAGAGUUUUGAGUUGUUGUUUAGGUGGAAGGCCGAGGUAAUGAAGCAGUGCCCCGGGAGUGUCGUUGAGAUUGAGGUACUUGAGGUGGAUGGUCAAGUAUAUUUCCACCGUUUUUUCUGUGCUCUUAAACCAUGCAUUGAUGGUUUCUUAGAAGGUUGUAGGCCUCAUUUGAGCAUAGAUGCUACUCCACUUAAUGGAGGGUGGAAUGGUCACUUGGCUGCAGCUGUAGCAGUUGAUGGUCACAAUUGGAUGUAUCCACUCGCUUAUGGCUUCAUAGCUUCUGAAACAACAGAUAACUGGACUUGGUUCAUGGAACAAUUAAAGAAGGCAAUAGGUGAUCCUCCACUCCUUGCUGUUUGUUCUGAUGCUUUCAAGGGCUUGGAGAAUGCAGUGAAGAAUGUAUUUCGAAAUGCAGAGCAAAGAGAAUGCUUUUAUCAUCUUGUGAAAAAUUUCACGAAGAGAUAUAGAGGGUUUGGCCAGAUAUAUCCUGCGGCAAGGGCUUACAGAGAAGACAUAUUCUAUGAUAAUAUAGCAAAAAUGGUAAGUGAAUCAGCAGAUGCAGUGAAAUGGUUACAUAACAAUCAUAAGCUAUUAUGGUAUAGGUGUGCUUUCAAUCCAGAAAUUAAGUGUGACUACAUAACUAGUAAUAUUGCUGAGUCAUUUAAUAACUGGAUUAGAGACCACAAAGACUUACCUGUUGCUGACCUUGCUGAUAAGAUUAGAGAAAUGAUCAUGGUACUUUGGAACAAGAGAAGAAAUAUUGCAUACAGGCUACCUGAAGGCAGGAUACUUCCAACUAUAAUGCAUCAGCUGAAGGCAAAUACUAGAGGCUUGGGACAUUUGAAAAUUGUACCAUGUUCUAAUUGGAGUGCAGAGGUGUGGGACAAGAGCAGCGACGUUGAGAGGCAUAUUGUCAAGUUACACCAAAGGACCAGUACAUGUCUUGAAUGGCAGCACACUGGUAAGCCAUGUCAACAUGUAUUGGCCUAUGUAACCCGCCAACUAUUACUCGGUGAAUAGAUUCAGGGCUGCUUAUGGAAGAGAGAUUGAGCCGAUGACAGACAAAACUCAAUGGCCACAAGUUGACCUACCAUUUUUAGUUGGUGCGCCUCUUGCUAAAUUACCUGUUGGAAGACGAAGGAAACUAAGAAGGAAGGGAUGGAUGGAAGGUGGCCACAAGAAAAAUGGUUCCAAAGAUGGUCCAUUUACCAACGAGGGUGAAGGUGAGAAGGGAGGUGACAACGAUAUUGCUCCAACAAAUGGAAAGGGACAGAAGAUGAUCAGAGGACCUAUGACUUGCAAAAAAUGCGGAGAGAAAGGCCACAGGCAAGCUAGUGCCAAGUGCCCACUCAAUGGGACAGCAAAAAAGAGGAAGCGUAGGCAACCUAGGAAGAAUGUUACAAAAGCUGCAGCAGCAGAACCUAGCACCCCAUGGAGGCCGACUAGAGAAGAAAUCCUACGGGAUAGUCCAGGAAGGGUCACUAGAAGCAAGCUUGCGAUGUUACUACGAGAGGGUACAUCUUCACAAACCGACACCACUAGUCCCAUGAGGAUGCCUACCGCGGCAGCACCAAAAAAGAUGACUCCAAAGAGAAAGCUACACAUUGGUUGAAUAAUUUUAGUUGUGAUGAGAUGUAAACUCAUACUUUAUUUUAUAUGACUUGGAUCUCGUUUGGAACUAAAUUAUGGUAUUCUGAGAUGAACUUGUUUAUGCUAGAAUCUCGGUUUUAUGAGACAAGCUUGUUUGUGCAAAAUUCAUGGUUUUGUCUAUUACUUGUAAUUGAGAUCUCCUUAUAAUUGCGUAUAGAUCAUCUUUGAUCAUCUUUCAUUUAUUCAUUGGGUUAGUGCUGCAAUUUUUGUGCAUGAUUGACCAUGUACAGUACAAUAUUUGGGGCAUAUGCAGCCGGCAGCUAGAAGCUGCAGCAAGUUCAGGAGCGGCUAGCAGCUUACCAGCCAUCCCAGGCGAGCCAGUGCUCUAGCCAUGGACAGGCGCCGGCCGGCCAGCCAUCCCAGGCUAGCCAAGCGACCAGCUAGCAGCGUGGGAGCACGUCAAUUGAAGCCCUGAGGGCAAUACAGUCACAUCAAGGUAAAAUACAUGUAUUUUAGUUGAGAAAAGUGAUUAAAAGGACCAAAUGUCAUGUAAAACAGAGUGCCAACGUUUCAAGUUUCGUUUUAGCAAAGUCGACGAUUGGAGUCCUAUAACUGCGAAGCGCAUUGUUUGGAGUCCUAUAAUUGCAAUUUUCUCGUGUGGGAUUUGUUACAAUCGUAGCAUUGGAAUGCUAAACCCCAUGGGAACAAAACCCUGUCAGAACAUACCAUUAAGUUCAGUUGUUGCUAGAACCAGCAGAAAAUUUGAAGUAAUUAACUAGAGGCAAUGAAAUAAUUGAGCUUGGCUUUGCAUAAAUUCCAUGCUUAUCACAACUGGUUGCCGCUUUGACUAAUUUCAAGAGCUGUAUAGUCCAUCAACCAAGGAUUAUUUUUUGAGAAAGGCAAUAUGUGUUGUCCGUAUU


Expression Capacity

HE: High-Expressed (TPM > upper quantile); ME: Medium-Expressed (TPM < upper quantile and TPM > lower quantile); LE: Low-Expressed (TPM < lower quantile); NE: Not Expressed.

HEP: High-Expressed Percentage; MEP: Medium-Expressed Percentage; LEP: Low-Expressed Percentage; NEP: Not Expressed Percentage.


NE_num:

246

NEP:

89.78%

LE_num:

3

LEP:

1.09%

ME_num:

23

MEP:

8.39%

HE_num:

2

HEP:

0.73%

Type:

HCR (High-Capacity ncRNA)


Tissue Specific Expression

cutoff: tau > 0.9 and Average expression in the tissue > 10


Tissue :

pollen

Tau :

0.98

Avg Expression:

48.91


Differential Expression

cutoff: log2(fold change) > 1 or log2(fold change) < -1 and p-adj < 0.01


Num. Condition log2(FoldChange) Padj
Tip: Osa-phasi05g0102 is not a differential expression ncRNA.